Author | Age (Y) | Clinical manifestation | Tumor size | Stage | Treatment | Outcome | OS |
---|---|---|---|---|---|---|---|
Aguirre, 1982 (Aguirre and Scully 1982) [10] | 14 | Increased AC, dyspnea, AUB | R/20 × 15 cm, 1278 g | IIIBa | RSO + OM + appendectomy; RAD | Progression | DOD, 2 M |
Aguirre, 1982 (Aguirre and Scully 1982) [10] | 13 | Abdominal pain and distention after RSO+ appendectomy | 8 × 5 cm | IIIa | Suboptimal CRS (LSO+ pelvic mass resection); melphalan×1; (CTX + KSM) × 2 | Progression | DOD, 20 M |
Aguirre, 1982 (Aguirre and Scully 1982) [10] | 16 | Abdominal pain; family history of tumor | L/15 cm, 464 g | IA | LSO+ appendectomy; TAH + RSO 6 days later; no adjuvant therapy | Relapse, 36 M | DOD, 47 M |
Aguirre, 1982 (Aguirre and Scully 1982) [10] | 17 | Pelvic mass | L/18 cm | IA | LSO + ROV biopsy; no adjuvant therapy | Complete remission | NED, 84 M |
Kanbour-Shak, 1993 (Kanbour-Shakir et al. 1993) [11] | 35 | Abdominal distention and increased AC for 2 M | R/18 × 10 × 10 cm | IIIAa | Complete surgical staging (TAH + RSO + LS (history of LOV resection) + OM + PLND+PALND); BEP × 6 | Complete remission | NED, 42 M |
Lawlor, 1997 (Lawlor et al. 1997) [12] | 13 | Intermittent fever, abdominal pain and diarrhea | Ovarian tumor 1448 g, omentum tumor 1855 g | IIICa | Suboptimal CRS (partial resection) (RSO + OM); (DDP + VP16 + doxorubicin+CTX) Q4W × 4, PBPC | Complete remission | NED, 18 M |
Kawauchi, 1998 (Kawauchi et al. 1998) [13] | 29 | Pelvic mass | L/22 × 17 × 15 cm; R/7 × 7 × 5 cm | IIICa | Optimal CRS (without any residual disease) (TAH + BSO + OM + PALN biopsy); CHEM×12 | Relapse | DOD, 11 M |
PUMCH case 1, 2003b | 33 | Backache and lower limb aching | 12.0 × 8.4 cm | IV | CHEM×11; RAD×2; PEB × 2; PVB × 1; RAD× 1; palliative surgery | Progression | DOD, 24 M |
Demirtas, 2004 (Demirtas et al. 2004) [14] | 25 | Abdominal pain and distention for 3 M | L/8 cm | IC1 | Fertility-sparing complete surgical staging (LSO + OM + partial ROV + PLND+PALND); BEP × 4; VIP × 6 when recurrent | Relapse, 3 M | NED, 28 M, CS twice |
Chow, 2004 (Chow et al. 2004) [15] | 13 | Abdominal pain and distention for 1 M | N/A | IIICa | Optimal CRS (without any residual disease) (BSO + OM + partial bladder); PEB × 2; RCRS and RAD | Progression | DOD, 17 M |
Kim, 2004 (Kim et al. 2004) [16] | 18 | Pelvic mass | 16 × 13 cm | IIIAa | Optimal CRS (without any residual disease) (RSO + Partial LOV + OM + PLN/PALN biopsy); TC × 6; RAD when recurrent; OP when intestinal obstruction; VACA | Relapse, 4 M | Died of septic shock, 10 M |
PUMCH case 2, 2005b | 59 | Pelvic mass | N/A | IIIa | Optimal CRS (with residual tumor less than 1 cm) | N/A | N/A |
Fischer, 2006 (Fischer et al. 2006) [17] | 79 | Abdominal distention for 4 M | 6 × 4 cm | III | Optimal CRS (TAH + BSO + OM + rectum and sigmoid colon resection+ partial bladder+ peritoneum+ PALND); CHEM | Complete remission | NED, 6 M |
Ateser, 2007 (Ateser et al. 2007) [18] | 28 | Stomach ache, nausea and vomiting at 12 weeks of gestation | 25 × 30 cm | N/A | RSO; doxorubicin+CTX + VCR; (at 37 weeks of gestation) CS + Optimal CRS (without any residual disease) (TAH + LSO + OM+ metastatic lesion); altered with VACA and PEI, RAD | Progression | DOD, 13 M |
Anfinan, 2009 (Anfinan et al. 2008) [19] | 31 | Abdominal pain and increased AC | 15 × 12 × 10 cm | IIICa | Optimal CRS (without any residual disease) (TAH + BSO + OM); Altered with VID and VIA; docetaxel+DDP | Progression | DOD, 15 M |
Ostwal, 2012 (Ostwal et al. 2012) [20] | 28 | Pelvic mass for 2 M | 12 × 11 × 10 cm | N/A | LOV resection; CHEM (Altered with VIE, VAC and VCD for 2 courses); CRS when recurrent | Relapse, 18 M | DOD, 18 M |
Chu, 2014 (Chu et al. 2014) [21] | 16 | Pelvic mass | 16.5 × 9.2 cm | IC | Fertility-sparing complete surgical staging (LSO + LPLND+OM); TC × 6 | Complete remission | NED,13 M |
PUMCH case 3, 2014b | 67 | Abdominal distention for 4 M | N/A | IIIa | Optimal CRS (without any residual disease) (history of TAH + LSO) (RSO + OM + appendectomy+partial small intestine and sigmoid colon resection); without adjuvant therapy | Progression | DOD, 6 M |
PUMCH case 4, 2016b | 14 | Abdominal distention for one week | 30 cm | IIIC | Optimal CRS (without any residual disease) (RSO + LOV biopsy+ OM + appendectomy+metastasis); TC × 1 | Progression | DOD, 5 M |